Review

  • HOME
  • ARTICLE CATEGORY
  • Review
Review
1692
Therapeutic mechanisms and beneficial effects of non-antidiabetic drugs in chronic liver diseases
Han Ah Lee, Young Chang, Pil Soo Sung, Eileen L. Yoon, Hye Won Lee, Jeong-Ju Yoo, Young-Sun Lee, Jihyun An, Do Seon Song, Young Youn Cho, Seung Up Kim, Yoon Jun Kim
Clin Mol Hepatol. 2022;28(3):425-472.   Published online July 1, 2022
View: 1854   Download: 142
1664
RNA interference as a novel treatment strategy for chronic hepatitis B infection
Rex Wan-Hin Hui, Lung-Yi Mak, Wai-Kay Seto, Man-Fung Yuen
Clin Mol Hepatol. 2022;28(3):408-424.   Published online February 17, 2022
View: 2232   Download: 334  Citations: 3
1658
Intrahepatic cholangiocarcinoma: Tumour heterogeneity and its clinical relevance
Mina Komuta
Clin Mol Hepatol. 2022;28(3):396-407.   Published online January 14, 2022
View: 1924   Download: 221  Citation: 1
Statin and aspirin for chemoprevention of hepatocellular carcinoma: Time to use or wait further?
Myung Ji Goh, Dong Hyun Sinn
Clin Mol Hepatol. 2022;28(3):380-395.   Published online January 13, 2022
View: 1582   Download: 98
1651
Imaging diagnosis of hepatocellular carcinoma: Future directions with special emphasis on hepatobiliary magnetic resonance imaging and contrast-enhanced ultrasound
Junghoan Park, Jeong Min Lee, Tae-Hyung Kim, Jeong Hee Yoon
Clin Mol Hepatol. 2022;28(3):362-379.   Published online December 27, 2021
View: 1742   Download: 140
1647
The best predictive model for hepatocellular carcinoma in patients with chronic hepatitis B infection
Jung Hwan Yu, Soon Gu Cho, Young-Joo Jin, Jin-Woo Lee
Clin Mol Hepatol. 2022;28(3):351-361.   Published online November 26, 2021
View: 1907   Download: 152
1640
Crosstalk between tumor-associated macrophages and neighboring cells in hepatocellular carcinoma
Pil Soo Sung
Clin Mol Hepatol. 2022;28(3):333-350.   Published online October 19, 2021
View: 12429   Download: 244  Citations: 3
1652
Cost-effectiveness of chronic hepatitis C screening and treatment
Hye Won Lee, Hankil Lee, Beom Kyung Kim, Young Chang, Jae Young Jang, Do Young Kim
Clin Mol Hepatol. 2022;28(2):164-173.   Published online December 27, 2021
View: 1949   Download: 107  Citation: 1
1644
MAFLD enhances clinical practice for liver disease in the Asia-Pacific region
Takumi Kawaguchi, Tsubasa Tsutsumi, Dan Nakano, Mohammed Eslam, Jacob George, Takuji Torimura
Clin Mol Hepatol. 2022;28(2):150-163.   Published online November 10, 2021
View: 2501   Download: 234  Citations: 6
1641
Approaches to quantifying hepatitis B virus covalently closed circular DNA
Henrik Zhang, Thomas Tu
Clin Mol Hepatol. 2022;28(2):135-149.   Published online October 22, 2021
View: 3069   Download: 240  Citation: 1
1636
The role of transjugular intrahepatic portosystemic shunt in patients with portal hypertension: Advantages and pitfalls
Hae Lim Lee, Sung Won Lee
Clin Mol Hepatol. 2022;28(2):121-134.   Published online September 27, 2021
View: 2592   Download: 237  Citation: 1
1626
Current knowledge about biomarkers of acute kidney injury in liver cirrhosis
Han Ah Lee, Yeon Seok Seo
Clin Mol Hepatol. 2022;28(1):31-46.   Published online August 2, 2021
View: 2851   Download: 184  Citation: 1
1624
Toward a complete cure for chronic hepatitis B: Novel therapeutic targets for hepatitis B virus
Sun Woong Kim, Jun Sik Yoon, Minjong Lee, Yuri Cho
Clin Mol Hepatol. 2022;28(1):17-30.   Published online July 20, 2021
View: 3921   Download: 441  Citations: 7
1637
The management of post-transplantation recurrence of hepatocellular carcinoma
Luckshi Rajendran, Tommy Ivanics, Marco PAW Claasen, Hala Muaddi, Gonzalo Sapisochin
Clin Mol Hepatol. 2022;28(1):1-16.   Published online October 5, 2021
View: 3255   Download: 192
1616
Recent advances in nonalcoholic fatty liver disease metabolomics
Hwi Young Kim
Clin Mol Hepatol. 2021;27(4):553-559.   Published online June 8, 2021
View: 5026   Download: 302  Citations: 5
1617
Treatment of direct oral anticoagulants in patients with liver cirrhosis and portal vein thrombosis
Ho Soo Chun, A Reum Choe, Minjong Lee, Yuri Cho, Hwi Young Kim, Kwon Yoo, Tae Hun Kim
Clin Mol Hepatol. 2021;27(4):535-552.   Published online June 16, 2021
View: 5286   Download: 380  Citations: 2
1606
Three heads are better than two: Hepatitis B core-related antigen as a new predictor of hepatitis B virus-related hepatocellular carcinoma
Jer-Wei Wu, Jia-Horng Kao, Tai-Chung Tseng
Clin Mol Hepatol. 2021;27(4):524-534.   Published online February 23, 2021
View: 9842   Download: 270  Citations: 7
1600
Changes in the epidemiology and management of bacterial infections in cirrhosis
Salvatore Piano, Marta Tonon, Paolo Angeli
Clin Mol Hepatol. 2021;27(3):437-445.   Published online January 28, 2021
View: 3238   Download: 252  Citations: 6
1611
β-blockers in advanced cirrhosis: More friend than enemy
Ki Tae Yoon, Hongqun Liu, Samuel S. Lee
Clin Mol Hepatol. 2021;27(3):425-436.   Published online December 3, 2020
View: 2574   Download: 184  Citations: 3
1578
Anti-fibrotic treatments for chronic liver diseases: The present and the future
Naoshi Odagiri, Tsutomu Matsubara, Misako Sato-Matsubara, Hideki Fujii, Masaru Enomoto, Norifumi Kawada
Clin Mol Hepatol. 2021;27(3):413-424.   Published online December 3, 2020
View: 9083   Download: 387  Citations: 5
1621
Entecavir versus tenofovir in patients with chronic hepatitis B: Enemies or partners in the prevention of hepatocellular carcinoma
Sung Won Lee, Jonggi Choi, Seung Up Kim, Young-Suk Lim
Clin Mol Hepatol. 2021;27(3):402-412.   Published online June 23, 2021
View: 3001   Download: 206  Citations: 12
1612
From nonalcoholic fatty liver disease to metabolic-associated fatty liver disease: Big wave or ripple?
Seong Hee Kang, Yuri Cho, Soung Won Jeong, Seung Up Kim, Jin-Woo Lee
Clin Mol Hepatol. 2021;27(2):257-269.   Published online March 22, 2021
View: 3969   Download: 341  Citations: 22
1583
Current and future strategies for the treatment of chronic hepatitis C
Omar Alshuwaykh, Paul Y. Kwo
Clin Mol Hepatol. 2021;27(2):246-256.   Published online December 3, 2020
View: 3138   Download: 194  Citations: 2
1580
Optimizing the management of intermediate-stage hepatocellular carcinoma: Current trends and prospects
Takuji Torimura, Hideki Iwamoto
Clin Mol Hepatol. 2021;27(2):236-245.   Published online December 3, 2020
View: 4428   Download: 275  Citations: 11
1585
Evaluation and management of extrahepatic manifestations of nonalcoholic fatty liver disease
Karn Wijarnpreecha, Elizabeth S. Aby, Aijaz Ahmed, Donghee Kim
Clin Mol Hepatol. 2021;27(2):221-235.   Published online December 3, 2020
View: 4009   Download: 306  Citations: 12
1579
The development of mesenchymal stem cell therapy in the present, and the perspective of cell-free therapy in the future
Yusuke Watanabe, Atsunori Tsuchiya, Shuji Terai
Clin Mol Hepatol. 2021;27(1):70-80.   Published online December 3, 2020
View: 6705   Download: 292  Citations: 18
1569
Recent updates on the management of autoimmune hepatitis
Atsumasa Komori
Clin Mol Hepatol. 2021;27(1):58-69.   Published online December 10, 2020
View: 6441   Download: 603  Citations: 8
1563
Updates in the quantitative assessment of liver fibrosis for nonalcoholic fatty liver disease: Histological perspective
Gwyneth Soon, Aileen Wee
Clin Mol Hepatol. 2021;27(1):44-57.   Published online November 19, 2020
View: 8337   Download: 277  Citations: 8
1568
The role of the gut microbiome and diet in the pathogenesis of non-alcoholic fatty liver disease
Erica Jennison, Christopher D. Byrne
Clin Mol Hepatol. 2021;27(1):22-43.   Published online December 10, 2020
View: 5326   Download: 352  Citations: 21
1566
Current understanding of primary biliary cholangitis
Atsushi Tanaka
Clin Mol Hepatol. 2021;27(1):1-21.   Published online December 3, 2020
View: 6384   Download: 505  Citations: 11

Clinical and
Molecular
Hepatology

Print ISSN: 2287-2728
Online ISSN: 2287-285X

Editorial Office
The Korean Association for the Study of the Liver
Room A1210, 53 Mapo-daero(MapoTrapalace, Dowha-dong), Mapo-gu, Seoul, 04158, Korea
TEL: +82-2-703-0051   FAX: +82-2-703-0071    E-mail: kasl@kams.or.kr
Copyright © The Korean Association for the Study of the Liver.         
COUNTER
TODAY : 511
TOTAL : 972689
Close layer